Milla Summanen

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Renal Cell Carcinoma

Gestational Age

Top Venues

Annals of hematology

Therapeutic advances in urology

Pfizer Oy

Universiteit Utrecht (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Oy Jul 29 2019

Finland

Medical Advisor

Medaffcon Oy Feb 11 2019

Finland

Scientific Advisor

University of Helsinki Jan 01 2014 - Apr 30 2019

Finland

Postdoctoral researcher :: Biosciences

Education History

Universiteit Utrecht Sep 01 2007 - Apr 02 2012

Netherlands

PHD :: Biology

Publications

Olivia Hölsä, Kaisa Teittinen, Anna Anttalainen, Liisa Ukkola-Vuoti, Milla Summanen, Kalle E Mattila
Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021. Therapeutic advances in urology 15 (2023)
Jarno Ruotsalainen, Leena Lehmus, Mervi Putkonen, Juha Lievonen, Alvar Kallio, Paavo Raittinen, Milla Summanen, Mikko Kosunen, Maarit Jaana Korhonen
Recent trends in incidence, survival and treatment of multiple myeloma in Finland - a nationwide cohort study. Annals of hematology (2023)
Tommi Ala-Kurikka, Alexey S Pospelov, Milla Summanen, Aleksander Alafuzoff, Samu N Kurki, Juha Voipio, Kai Kaila
A physiologically validated rat model of term birth asphyxia with seizure generation after, not during, brain hypoxia. Epilepsia 62 (4) (2020)
Dorottya Kelen, Csilla Andorka, Miklós Szabó, Aleksander Alafuzoff, Kai Kaila, Milla Summanen
Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome. PloS one 12 (9) (2017)